The Predictive Value of Liver Tests for the Presence of Liver Metastases

References

• Paget S. The distribution of secondary growths in cancer of the breast. The Lancet. 133(3421), 571–573 (1889).
   Google Scholar
• Weiss L. Comments on hematogenous metastatic patterns in humans as revealed by autopsy. Clin. Exp. Metastasis 10, 191–199 (1992).
   PubMed Web of Science ®Google Scholar
• Tsilimigras DI, Brodt P, Clavien PA et al. Liver metastases. Nat Rev Dis Primers. 7(27), 1–23 (2021).
   PubMedGoogle Scholar
• Carr J, Carr I. The origin of cancer metastasis. Canadian bulletin of medical history. 22(2), 353–358 (2005).
   PubMedGoogle Scholar
• Horn SR, Stoltzfus KC, Lehrer EJ et al. Epidemiology of liver metastases. Cancer Epidemiol. 67, 101760 (2020).
   PubMed Web of Science ®Google Scholar
• Slesser AAP, Simillis C, Goldin R, Brown G, Mudan S, Tekkis PP. A meta-analysis comparing simultaneous versus delayed resections in patients with synchronous colorectal liver metastases. Surg. Oncol. 22(1), 36–47 (2013).
   PubMed Web of Science ®Google Scholar
• Wagner JS, Adson MA, Adson MH, Ilstrup DM, Van Heerden JA. The natural history of hepatic metastases from colorectal cancer a comparison with resective treatment. Ann. Surg. 199(5), 502–508 (1984).
   PubMed Web of Science ®Google Scholar
• Wu XZ, Ma F, Wang XL. Serological diagnostic factors for liver metastasis in patients with colorectal cancer. World J Gastroenterol. 16(32), 4084–4088 (2010).
   PubMed Web of Science ®Google Scholar
• Moretta L. Epidemiology of colorectal liver metastases. Surg. Oncol. 16(1), 3–5 (2007).
   PubMed Web of Science ®Google Scholar
• van de Velde CJH. Treatment of liver metastases of colorectal cancer. Ann. Oncol. 17(4), 727 (2006).
   PubMed Web of Science ®Google Scholar
• Cheng YC, Ueno NT. Improvement of survival and prospect of cure in patients with metastatic breast cancer. Breast Cancer. 19(3), 191–199 (2012).
   PubMed Web of Science ®Google Scholar
• Hsu C, Huang CS, Chao TY et al. Phase II trial combining paclitaxel with 24-hour infusion cisplatin for chemotherapy-naïve patients with locally advanced or metastatic breast carcinoma. Cancer 95(10), 2044–2050 (2002).
   PubMed Web of Science ®Google Scholar
• Cao R, Wang LP. Serological diagnosis of liver metastasis in patients with breast cancer. Cancer Biol Med. 9(1), 57–62 (2012).
   PubMedGoogle Scholar
• Nakazawa K, Kurishima K, Tamura T et al. Specific organ metastases and survival in small cell lung cancer. Oncol Lett. 4(4), 617–620 (2012).
   PubMed Web of Science ®Google Scholar
• Tamura T, Kurishima K, Nakazawa K et al. Specific organ metastases and survival in metastatic non-small-cell lung cancer. Mol Clin Oncol. 3(1), 217–221 (2015).
   PubMedGoogle Scholar
• Faries MB, Leung A, Morton DL et al. A 20-Year experience of hepatic resection for melanoma: is there an expanding role? J. Am. Coll. Surg. 219(1), 62–68 (2014).
   PubMed Web of Science ®Google Scholar
• Nordlinger B, Sorbye H, Glimelius B et al. Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial. Lancet Oncol. 14(12), 1208–1215 (2013).
   PubMed Web of Science ®Google Scholar
• Pawlik TM, Choti MA. Surgical therapy for colorectal metastases to the liver. Journal of Gastrointestinal Surgery. 11(8), 1057–1077 (2007).
   PubMed Web of Science ®Google Scholar
• Bolhuis K, Kos M, van Oijen MGH, Swijnenburg RJ, Punt CJA. Conversion strategies with chemotherapy plus targeted agents for colorectal cancer liver-only metastases: a systematic review. Eur. J. Cancer 141, 225–238 (2020).
   PubMed Web of Science ®Google Scholar
• Lee YT. Malignant melanoma: pattern of metastasis. CA Cancer J. Clin. 30(3), 137–142 (1980).
   PubMed Web of Science ®Google Scholar
• Locker GY, Hamilton S, Harris J et al. ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J. Clin. Oncol. 24(33), 5313–5327 (2006).
   PubMed Web of Science ®Google Scholar
• Jiang Z, Li C, Zhao Z, Liu Z et al. Abnormal liver function induced by space-occupying lesions is associated with unfavorable oncologic outcome in patients with colorectal cancer liver metastases. Biomed Res Int. 2018, 1–7 (2018).
   Web of Science ®Google Scholar
• Saif MW, Alexander D, Wicox CM. Serum alkaline phosphatase level as a prognostic tool in colorectal cancer: a study of 105 patients. J Appl Res. 5(1), 88–95 (2005).
   PubMedGoogle Scholar
• Mayne PD, Thakrar S, Rosalki SB, Foo AY, Parbhoot S. Identification of bone and liver metastases from breast cancer by measurement of plasma alkaline phosphatase isoenzyme activity. J. Clin. Pathol. 40, 398–403 (1987).
   PubMed Web of Science ®Google Scholar
• Bonfanti G, Bombelli L, Bozzetti F et al. The role of CEA and liver function tests in the detection of hepatic metastases from colo-rectal cancer. HPB Surgery. 3, 29–37 (1990).
   PubMedGoogle Scholar
• White DR, Maloney JJIII, Muss HB et al. Serum alkaline phosphatase determination value in the staging of advanced breast cancer. JAMA 242(11), 1147–1149 (1979).
   PubMed Web of Science ®Google Scholar
• Tempero MA, Petersen RJ, Zetterman RK, Lemon HM, Gurney J. Detection of metastatic liver disease use of liver scans and biochemical liver tests. JAMA 248(11), 1329–1332 (1982).
   PubMed Web of Science ®Google Scholar
• de Ridder J, de Wilt J, Simmer F, Overbeek L, Lemmens V, Nagtegaal I. Incidence and origin of histologically confirmed liver metastases: an explorative case-study of 23,154 patients. Oncotarget. 7(34), 55368–55376 (2016).
   PubMedGoogle Scholar
• Goswami R, Babich M, Farah KF. Occult breast malignancy masquerading as acute hepatic failure. Gastroenterol Hepatol. 7(1), 62–65 (2011).
   Google Scholar
• Vivas S, Linares A. Diffuse Liver metastasis mimicking cirrhosis in a patient with choroid melanoma. J. Hepatol. 30, 126 (1999).
   Google Scholar